What else does weight-loss drug Ozempic do? 5 unexpected health benefits - Emerging scientific research indicates that ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Summary: A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

None had been diagnosed with Alzheimer disease and related dementias at the start of the study. The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of ...

Semaglutide (Ozempic) was approved for treating type 2 diabetes in 2017, but has since been used as a weight-loss drug. Now, an analysis of Alzheimer’s diagnoses in people who were prescribed ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

Semaglutide — the powerful ingredient behind Wegovy and Ozempic — has long been hailed ... seems to be promising in reducing the risk of Alzheimer's disease and related dementias (ADRD)'.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...